Chuke Nwachuku

Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

William C. Cushman, Charles E. Ford, Jeffrey A. Cutler et al. · Journal of Clinical Hypertension · 2002 · 985 citations · Full text

Medicine, Cardiology, Preventive Medicine +17

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Jackson T. Wright, William C. Cushman, Barry R. Davis et al. · Controlled Clinical Trials · 2001 · 311 citations

Medicine, Cardiology, Preventive Medicine +14

Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Frans H. H. Leenen, Chuke Nwachuku, Henry R. Black et al. · Hypertension · 2006 · 169 citations

Medicine, Cardiology, Pharmacotherapy +17

Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension

Henry R. Black, Barry R. Davis, Joshua I. Barzilay et al. · Diabetes Care · 2008 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial

Frans L. Moll, Iris Baumgärtner, Michael R. Jaff et al. · Journal of Endovascular Therapy · 2018 · 97 citations · Full text

Medicine, Pharmacotherapy, Surgery +17